Nijhawan Pardeep
Known title: Chief Executive OfficerCIK: 0001777962
Nijhawan Pardeep's purchase track record
How the stock did after each of Nijhawan Pardeep's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
8
of 8 since March 9, 2022
Stock higher 6 months later
38%
3 months: 38%
Median 6-month return
-38.0%
3 months: -20.1%
Beat the S&P 500
25%
median -34.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/10/2026 | EDSA | $7K | -28.4% | -31.4% | +13.2% |
| 2/26/2026 | EDSA | $223K | +407.1% | +196.8% | +11.9% |
| 3/25/2024 | EDSA | $20K | +4.8% | +6.0% | +9.6% |
| 6/30/2022 | EDSA | $32K | -11.8% | +8.1% | +1.7% |
| 5/24/2022 | EDSA | $13K | +4.0% | -50.3% | +1.6% |
| 3/29/2022 | EDSA | $18K | -50.2% | -53.9% | -21.3% |
| 3/17/2022 | EDSA | $14K | -51.3% | -48.1% | -11.6% |
| 3/9/2022 | EDSA | $32K | -37.6% | -44.5% | -7.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| EDSA | ▲ Buy | Grant | 6,893 | $0 | 10/5/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 5,714 | $0 | 9/1/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 5,324 | $0 | 8/3/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 3,378 | $0 | 7/2/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 153,550 | $800K | 6/16/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 1,671 | $0 | 6/1/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 96,913 | $0 | 5/27/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 1,159 | $0 | 5/1/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 2,578 | $0 | 4/1/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,000 | $7K | 3/10/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 10,000 | $39K | 3/5/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 10,000 | $43K | 3/4/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 10,000 | $36K | 3/3/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $4K | 3/2/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,000 | $2K | 3/2/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 10,016 | $0 | 3/2/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 30,000 | $67K | 2/27/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 20,571 | $32K | 2/26/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 82,236 | $0 | 2/19/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 11,168 | $0 | 2/2/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 10,444 | $0 | 1/5/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 8,766 | $0 | 12/1/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 6,968 | $0 | 11/3/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 5,908 | $0 | 10/2/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 5,981 | $0 | 9/11/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 6,802 | $0 | 8/1/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 7,186 | $0 | 7/2/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 7,644 | $0 | 6/2/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 263,200 | $0 | 5/29/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 6,392 | $0 | 5/2/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 5,784 | $0 | 4/1/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 6,339 | $0 | 3/3/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 8,264 | $0 | 2/3/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 8,476 | $0 | 1/6/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 6,420 | $0 | 12/2/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 4,630 | $0 | 11/12/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 3,300 | $0 | 10/2/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 3,055 | $0 | 9/3/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 3,317 | $0 | 8/1/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 4,015 | $0 | 7/2/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 4,785 | $0 | 6/3/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 3,083 | $0 | 5/1/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 3,253 | $0 | 4/1/2024 | View on chart |
| EDSA | ▲ Buy | Open Market | 5,000 | $20K | 3/25/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 2,765 | $0 | 3/1/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 2,978 | $0 | 2/1/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 2,908 | $0 | 1/8/2024 | View on chart |
| EDSA | ▲ Buy | Grant | 99,300 | — | 8/4/2023 | View on chart |
| EDSA | ▲ Buy | Grant | 228,262 | $257K | 11/2/2022 | View on chart |
| EDSA | ▲ Buy | Grant | 228,262 | $257K | 11/2/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 20,000 | $32K | 6/30/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 5,000 | $10K | 5/27/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $4K | 5/24/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $6K | 3/31/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $6K | 3/30/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $6K | 3/29/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $8K | 3/18/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 397 | $1K | 3/17/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,603 | $5K | 3/17/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $6K | 3/15/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $6K | 3/11/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 5,000 | $15K | 3/11/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,500 | $5K | 3/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Edesa Biotech Included in After-Market Movers List
Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.
Edesa Biotech Included in After-Market Movers List. Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.